Genflow Biosciences (LON:GENF) Announces Earnings Results

Genflow Biosciences (LON:GENF) announced its quarterly earnings results on Tuesday. The company reported GBX (0.08) EPS for the quarter, Digital Look Earnings reports. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.

Genflow Biosciences Price Performance

Genflow Biosciences stock opened at GBX 1.98 on Tuesday. The stock’s 50 day moving average is GBX 2.01 and its 200 day moving average is GBX 2.08. The firm has a market cap of £11.21 million, a P/E ratio of -5.96 and a beta of 2.29. Genflow Biosciences has a one year low of GBX 0.90 and a one year high of GBX 3.12.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.